EE9900589A - Farmatseutilised kompositsioonid limaskestale kandmiseks - Google Patents

Farmatseutilised kompositsioonid limaskestale kandmiseks

Info

Publication number
EE9900589A
EE9900589A EEP199900589A EEP9900589A EE9900589A EE 9900589 A EE9900589 A EE 9900589A EE P199900589 A EEP199900589 A EE P199900589A EE P9900589 A EEP9900589 A EE P9900589A EE 9900589 A EE9900589 A EE 9900589A
Authority
EE
Estonia
Prior art keywords
application
mucosa
pharmaceutical compositions
pharmaceutical
mosm
Prior art date
Application number
EEP199900589A
Other languages
English (en)
Inventor
Nishibe Yoshihisa
Konoshita Wataru
Kawabe Hiroyuki
Original Assignee
Teijin Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26450407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE9900589(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teijin Limited filed Critical Teijin Limited
Publication of EE9900589A publication Critical patent/EE9900589A/et
Publication of EE05072B1 publication Critical patent/EE05072B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP199900589A 1998-04-21 1999-04-21 Farmatseutilised kompositsioonid limaskestale kandmiseks EE05072B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11088898 1998-04-21
JP11088798 1998-04-21
PCT/JP1999/002126 WO1999053899A1 (en) 1998-04-21 1999-04-21 Medicinal compositions for application to mucosa

Publications (2)

Publication Number Publication Date
EE9900589A true EE9900589A (et) 2000-08-15
EE05072B1 EE05072B1 (et) 2008-10-15

Family

ID=26450407

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900589A EE05072B1 (et) 1998-04-21 1999-04-21 Farmatseutilised kompositsioonid limaskestale kandmiseks

Country Status (36)

Country Link
US (3) US6939559B1 (et)
EP (1) EP0998916B1 (et)
JP (2) JP5142420B2 (et)
KR (1) KR100686901B1 (et)
CN (1) CN1304052C (et)
AT (1) ATE336986T1 (et)
AU (1) AU757772B2 (et)
BG (1) BG64919B1 (et)
BR (1) BRPI9906372B8 (et)
CA (1) CA2294457C (et)
CY (1) CY1105771T1 (et)
CZ (1) CZ298466B6 (et)
DE (1) DE69932905T2 (et)
DK (1) DK0998916T3 (et)
EA (1) EA002967B1 (et)
EE (1) EE05072B1 (et)
ES (1) ES2272064T3 (et)
GE (1) GEP20022669B (et)
GT (2) GT199900180A (et)
HR (1) HRP990402C1 (et)
HU (1) HU226712B1 (et)
ID (1) ID24818A (et)
IL (1) IL133614A (et)
IS (1) IS2453B (et)
NO (1) NO328270B1 (et)
NZ (1) NZ501950A (et)
PL (1) PL197875B1 (et)
PT (1) PT998916E (et)
RS (1) RS49764B (et)
SI (1) SI0998916T1 (et)
SK (1) SK286101B6 (et)
TR (1) TR199903193T1 (et)
TW (1) TWI243687B (et)
UA (1) UA77640C2 (et)
WO (1) WO1999053899A1 (et)
ZA (1) ZA997727B (et)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261836B1 (en) * 1996-10-01 2001-07-17 Geron Corporation Telomerase
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
PL373433A1 (en) * 2002-08-30 2005-08-22 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
US20060216245A1 (en) * 2002-12-10 2006-09-28 Showa Yakuhin Kako Co., Ltd. Composition for local anesthesia
PT1572217E (pt) * 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
US20050025825A1 (en) 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US8371292B2 (en) * 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP4128521B2 (ja) * 2003-12-19 2008-07-30 信越化学工業株式会社 ゲル状シート及びその製造方法
US20090215898A1 (en) 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1591106B1 (en) * 2004-04-28 2009-07-22 Shin-Etsu Chemical Co., Ltd. Film preparation and process for preparing the same
US20070231396A1 (en) * 2006-03-29 2007-10-04 Ray Charles D Medication spray formulation
EP2265250A2 (en) * 2008-03-14 2010-12-29 Cephalon, Inc. Enhanced transmucosal composition and dosage form
ES2657686T3 (es) * 2009-06-24 2018-03-06 Lipoid Gmbh Composición para aplicaciones cosméticas, farmacéuticas o dietéticas
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
ES2951828T3 (es) 2010-09-23 2023-10-25 Leading Biosciences Inc Administración de inhibidores de serina proteasa al estómago
ES2738914T3 (es) 2011-01-05 2020-01-27 Prenatal Int Gmbh Composición acuosa hipotónica con bajo contenido de cloruro, con o sin fosfolípidos
ES2375784B1 (es) 2011-12-22 2013-01-24 Laboratorios Kin S.A. Gel de ácido tranexámico
EP3122349B1 (en) 2014-03-25 2021-12-22 Leading Biosciences, Inc. Compositions for the treatment of autodigestion
CN104473864B (zh) * 2014-11-25 2017-02-22 陈长潭 一种卡络磺钠半固体制剂及其制备方法
TWI745313B (zh) 2015-10-30 2021-11-11 日商帝人製藥股份有限公司 鼻黏膜投與用醫藥組成物
US11666532B2 (en) 2018-01-19 2023-06-06 Hyloris Developments Sa Tranexamic acid oral solution
JP7825562B2 (ja) * 2020-09-25 2026-03-06 アステラス製薬株式会社 耳内投与用の医薬組成物
JP7842983B2 (ja) * 2021-02-25 2026-04-09 学校法人神戸学院 腸管吸収用補助剤及びその利用方法
EP4062919A1 (de) 2021-03-24 2022-09-28 Prenatal International GmbH Eine oder mehrere zusammensetzungen auf basis des menschlichen fruchtwassers zur anwendung in einem verfahren zur enteralen ernährung, zur enteralen ernährungsergänzung und/oder zur behandlung und/oder versorgung von kapillararmen schichten

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
IL70489A0 (en) 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB8514090D0 (en) 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
JPS6034925A (ja) * 1983-08-04 1985-02-22 Mitsubishi Chem Ind Ltd ２−ヒドロキシイソフタルアルデヒド類の製造法
ATE151286T1 (de) 1983-11-14 1997-04-15 Columbia Lab Inc Bioadhäsive mittel
JPS60123426A (ja) * 1983-12-07 1985-07-02 Eisai Co Ltd 経鼻投与用セクレチン製剤
JPS60224616A (ja) 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPS63303031A (ja) 1987-05-30 1988-12-09 Nippon Piston Ring Co Ltd コンプレッサ用ベ−ン
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
PT88490B (pt) * 1987-09-14 1992-11-30 Novo Nordisk As Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
ATE113841T1 (de) 1989-10-31 1994-11-15 Columbia Lab Inc Mittel zur feuchthaltung vaginalen gewebes.
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
EP0578780B1 (en) 1991-04-03 2003-07-02 Keimowitz, Rudolph, M.D. Suppression of thromboxane levels by percutaneous administration of aspirin
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
WO1993012765A1 (en) * 1991-12-27 1993-07-08 Merck & Co., Inc. A controlled release drug dispersion delivery device
CN1075081A (zh) * 1992-02-01 1993-08-11 解放军陆军第44医院 复方胶体麻醉剂的配制方法
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) * 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) * 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
CN1155368C (zh) 1996-02-27 2004-06-30 帝人株式会社 鼻腔给药的粉剂组合物
JPH09253220A (ja) 1996-03-26 1997-09-30 Kaajiopeeshingu Res Lab:Kk 生体内に植え込み可能なリード
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
RU2111829C1 (ru) 1996-10-09 1998-05-27 Буркин Сергей Павлович Способ непрерывного получения тонкой металлической полосы и машина для его осуществления
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
JP4009355B2 (ja) 1997-10-02 2007-11-14 村樫石灰工業株式会社 芝草地に発生するコケ・藻類の防除用組成物及び防除方法
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок

Also Published As

Publication number Publication date
DE69932905T2 (de) 2007-04-05
US20050181054A1 (en) 2005-08-18
BG64919B1 (bg) 2006-09-29
CA2294457C (en) 2008-06-17
IS5312A (is) 1999-12-20
EP0998916B1 (en) 2006-08-23
BRPI9906372B8 (pt) 2021-05-25
PL197875B1 (pl) 2008-05-30
US6939559B1 (en) 2005-09-06
PT998916E (pt) 2006-12-29
HU226712B1 (en) 2009-07-28
BRPI9906372B1 (pt) 2015-09-01
ID24818A (id) 2000-08-24
GT199900180AA (es) 2006-08-29
CA2294457A1 (en) 1999-10-28
BR9906372A (pt) 2000-07-11
CZ298466B6 (cs) 2007-10-10
HRP990402A2 (en) 2000-04-30
DE69932905D1 (de) 2006-10-05
BG104020A (en) 2000-05-31
GEP20022669B (en) 2002-04-25
CN1304052C (zh) 2007-03-14
IL133614A (en) 2004-12-15
CN1272784A (zh) 2000-11-08
ATE336986T1 (de) 2006-09-15
DK0998916T3 (da) 2006-12-11
HUP0002512A2 (hu) 2000-12-28
KR100686901B1 (ko) 2007-02-26
AU3534399A (en) 1999-11-08
US7235247B2 (en) 2007-06-26
US20030008019A1 (en) 2003-01-09
EA002967B1 (ru) 2002-12-26
SK182399A3 (en) 2000-07-11
KR20010014067A (ko) 2001-02-26
EP0998916A4 (en) 2002-06-19
SK286101B6 (sk) 2008-03-05
AU757772B2 (en) 2003-03-06
IL133614A0 (en) 2001-04-30
WO1999053899A1 (en) 1999-10-28
GT199900180A (es) 2001-12-18
NO328270B1 (no) 2010-01-18
UA77640C2 (uk) 2007-01-15
ZA997727B (en) 2000-10-12
CZ460499A3 (cs) 2000-05-17
HRPK990402B1 (hr) 2001-08-31
TWI243687B (en) 2005-11-21
HUP0002512A3 (en) 2001-03-28
IS2453B (is) 2008-11-15
PL337534A1 (en) 2000-08-28
CY1105771T1 (el) 2011-02-02
ES2272064T3 (es) 2007-04-16
EA200000060A1 (ru) 2000-08-28
RS49764B (sr) 2008-04-04
SI0998916T1 (sl) 2007-02-28
NO996323L (no) 2000-02-18
YU54499A (sh) 2002-06-19
HRP990402C1 (en) 2008-09-30
NO996323D0 (no) 1999-12-20
EP0998916A1 (en) 2000-05-10
EE05072B1 (et) 2008-10-15
NZ501950A (en) 2003-04-29
TR199903193T1 (xx) 2000-11-21
JP5142420B2 (ja) 2013-02-13
JP2004099624A (ja) 2004-04-02

Similar Documents

Publication Publication Date Title
EE05072B1 (et) Farmatseutilised kompositsioonid limaskestale kandmiseks
CO5150154A1 (es) Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
PT86536A (pt) Sistema terapeutico para ingredientes activos pouco soluveis
PT936905E (pt) Pelicula soluvel em agua ou camada soluvel em agua que possuem molhabilidade imediata para aplicacao oral
ATE213405T1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
BR9913135A (pt) Formulação oral
CO5261494A1 (es) Composiciones farmaceuticas acuosas e hipotonicas de ciclesonida que presentan absorcion nasal mejorada
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
BR0011864A (pt) Formulações farmacêuticas
SV1999000181A (es) Composicion farmaceutica para ser aplicada a las mucosas ref. er/cr-203.689
CR6122A (es) Composicion farmaceutica para ser aplicada a las mucosas
AR019245A1 (es) Composicion farmaceutica para ser aplicada a las mucosas
UY24851A1 (es) Derivados de ácidos n-acil-alfa-aminados

Legal Events

Date Code Title Description
HK1A Erratum in gazette
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231